Zurzuvae
My Prescription
Payment
Select pharmacy
$17,669.61
Print or send this coupon to your phone
AlbertsonsPowered byAbout Zurzuvae
Drug Details
Zuranolone, marketed as Zurzuvae, is an oral medication specifically designed to address postpartum depression, a form of depression that occurs after childbirth. It is the first FDA-approved oral treatment for this condition. The medication is intended to be taken once daily for a duration of two weeks and can be used on its own or in combination with other oral antidepressants. The exact mechanism of zuranolone is not entirely understood, but it is believed to function by modulating the gamma-aminobutyric acid (GABA) A receptors, thereby helping to restore the balance of natural substances in the brain and improving mood. Common side effects associated with Zurzuvae include drowsiness, dizziness, and diarrhea. Always consult your healthcare provider before starting any new medication to ensure it is appropriate and safe for your individual health needs.
Price history for Zurzuvae
28 Capsules, 25MG
Average retail price for Zurzuvae
Average SaveHealth price for Zurzuvae
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Zurzuvae dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 20MG | 14 Capsules | $8,838.81 | $631.34 |
| 25MG | 28 Capsules | $17,669.61 | $631.06 |
| 30MG | 14 Capsules | $17,669.61 | $1,262.12 |
Zurzuvae FAQs
Zurzuvae (zuranolone) is a medication that has been approved for the treatment of postpartum depression. Clinical trials have shown that it can be effective in reducing depressive symptoms in some individuals. However, as with any medication, its effectiveness can vary from person to person. It is important for patients to discuss with their healthcare provider to determine if it is an appropriate treatment option for their specific condition.
Zurzuvae is used for the treatment of postpartum depression in adults.
Yes, Zurzuvae is available in the USA. It is a medication approved by the FDA for the treatment of postpartum depression.
Zurzuvae is not specifically indicated for the treatment of anxiety. It is important for individuals to consult with a healthcare provider to determine the most appropriate treatment for anxiety, as there are other medications and therapies that are more commonly used for this condition.
Zurzuvae, also known as zuranolone, was approved by the FDA in August 2023 for the treatment of postpartum depression. Availability can vary based on factors such as distribution and pharmacy stocking, so it is recommended to check with local pharmacies or healthcare providers for the most current information on its availability.